Healthia Future Growth
Future criteria checks 4/6
Healthia is forecast to grow earnings and revenue by 40.3% and 8.2% per annum respectively.
Key information
40.3%
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 20.9% |
Revenue growth rate | 8.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 13 Sep 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2025 | 298 | 15 | 25 | 43 | 1 |
6/30/2024 | 280 | 14 | 26 | 45 | 1 |
6/30/2023 | 253 | 5 | 15 | 23 | N/A |
3/31/2023 | 242 | 3 | 14 | 20 | N/A |
12/31/2022 | 232 | 1 | 12 | 18 | N/A |
9/30/2022 | 216 | -1 | 13 | 18 | N/A |
6/30/2022 | 200 | -3 | 14 | 17 | N/A |
3/31/2022 | 184 | -2 | 13 | 16 | N/A |
12/31/2021 | 168 | 0 | 12 | 15 | N/A |
9/30/2021 | 152 | 3 | 18 | 21 | N/A |
6/30/2021 | 137 | 5 | 23 | 26 | N/A |
3/31/2021 | 121 | 6 | 26 | 28 | N/A |
12/31/2020 | 105 | 7 | 29 | 31 | N/A |
9/30/2020 | 96 | 5 | 22 | 24 | N/A |
6/30/2020 | 87 | 3 | 16 | 17 | N/A |
3/31/2020 | 83 | 1 | 9 | 10 | N/A |
12/31/2019 | 79 | 0 | 2 | 3 | N/A |
9/30/2019 | 72 | 0 | -1 | 1 | N/A |
6/30/2019 | 65 | -1 | -4 | -2 | N/A |
3/31/2019 | 57 | -2 | -3 | 0 | N/A |
12/31/2018 | 48 | -3 | -1 | 2 | N/A |
9/30/2018 | 41 | -2 | -1 | 1 | N/A |
6/30/2018 | 34 | -2 | 0 | 1 | N/A |
6/30/2017 | 67 | 4 | N/A | N/A | N/A |
6/30/2016 | 67 | 4 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HE3's forecast earnings growth (40.3% per year) is above the savings rate (0.5%).
Earnings vs Market: HE3's earnings (40.3% per year) are forecast to grow faster than the German market (14.7% per year).
High Growth Earnings: HE3's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: HE3's revenue (8.2% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: HE3's revenue (8.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HE3's Return on Equity is forecast to be high in 3 years time